Online citations, reference lists, and bibliographies.

Proposed Staging System For Patients With HPV-Related Oropharyngeal Cancer Based On Nasopharyngeal Cancer N Categories.

Kristina R Dahlstrom, Adam S Garden, William N. William, Ming Yann Lim, Erich M Sturgis
Published 2016 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
PURPOSE Patients with human papillomavirus (HPV)-related oropharyngeal cancer (OPC) generally present with more advanced disease but have better survival than patients with HPV-unrelated OPC. The current American Joint Commission on Cancer (AJCC)/Union for International Cancer Control (UICC) TNM staging system for OPC was developed for HPV-unrelated OPC. A new staging system is needed to adequately predict outcomes of patients with HPV-related OPC. PATIENTS AND METHODS Patients with newly diagnosed HPV-positive OPC (by p16 immunohistochemistry or in situ hybridization) treated at our institution from January 2003 through December 2012 were included. By using recursive partitioning analysis (RPA), we developed new stage groupings with both traditional OPC regional lymph node (N) categories and nasopharyngeal carcinoma (NPC) N categories. Survival was estimated by the Kaplan-Meier method, and the relationship between stage and survival was examined by using Cox proportional hazards regression analysis. RESULTS A total of 661 patients with HPV-positive OPC met the inclusion criteria. With the traditional TNM staging system, there was no difference in survival between stages (P = .141). RPA with NPC N categories resulted in more balanced stage groups and better separation between groups for 5-year survival than RPA with traditional OPC N categories. With the stage groupings that were based in part on NPC N categories, the risk of death increased with increasing stage (P for trend < .001), and patients with stage III disease had five times the risk of death versus patients with stage IA disease. CONCLUSION New stage groupings that are based on primary tumor (T) categories and NPC N categories better separate patients with HPV-positive OPC with respect to survival than does the current AJCC/UICC TNM staging system. Although confirmation of our findings in other patient populations is needed, we propose consideration of NPC N categories as an alternative to the traditional OPC N categories in the new AJCC/UICC TNM staging system that is currently being developed.
This paper references
10.1097/PAP.0b013e3181f895c1
Human Papillomavirus Detection in Head and Neck Squamous Cell Carcinomas
Anthony N. Snow (2010)
10.1002/jso.23292
Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors.
Jan Klozar (2013)
10.1200/JCO.2009.23.1670
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
Wei Shi (2009)
10.1002/cncr.27727
An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair.
Kristina R Dahlstrom (2013)
10.1080/00016480601110170
The incidence of tonsillar cancer in Sweden is increasing
>Lalle Hammarstedt (2007)
10.1200/JCO.2008.20.2853
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Pernille Lassen (2009)
10.1093/biomet/92.4.965
Concordance Probability and Discriminatory Power in Proportional Hazards Regression
Mithat Gonen (2005)
10.1201/B13389-6
Assessment and staging
Nick Roland (2012)
10.1016/J.YPED.2010.12.093
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
James A. Stockman (2012)
10.1002/hed.23697
Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
Matthew Alex Ward (2015)
10.1309/AJCP1LLX8QMDXHHO
Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma.
Ming Guo (2011)
10.1200/JCO.2014.58.6412
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Shao Hui Huang (2015)
10.1097/PAS.0b013e318253a2d1
Validation of Methods for Oropharyngeal Cancer HPV Status Determination in US Cooperative Group Trials
Richard C K Jordan (2012)
10.1093/annonc/mds205
Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer.
Angela M. Hong (2013)
10.1093/jnci/djn011
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Carole Fakhry (2008)
Pharynx, in AJCC Cancer Staging Manual (ed
S Edge (2010)
10.1002/cncr.29402
Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Florence K. Keane (2015)
10.1093/annonc/mdq210
p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.
Claude A. Fischer (2010)
10.1002/ijc.22980
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.
Serge J. Smeets (2007)
10.1097/MLG.0b013e31813e5fbb
Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus.
Joel A Ernster (2007)
10.1128/JCM.01299-07
Evaluation of a Commercialized In Situ Hybridization Assay for Detecting Human Papillomavirus DNA in Tissue Specimens from Patients with Cervical Intraepithelial Neoplasia and Cervical Carcinoma
Ming Guo (2007)
10.1007/978-1-4757-3027-2_8
Analysis of Censored Data: Survival Trees
Heping Zhang (1999)
10.1002/hed.23438
Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Matthew E Spector (2014)
10.1200/JCO.2007.12.7662
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.
Bhavna Kumar (2008)
10.1200/JCO.2011.36.4596
Human papillomavirus and rising oropharyngeal cancer incidence in the United States.
Anil K Chaturvedi (2011)
10.1002/1097-0142(20010915)92:6<1484::AID-CNCR1473>3.0.CO;2-W
A comparison of published head and neck stage groupings in carcinomas of the tonsillar region.
Patti A. Groome (2001)
10.1200/JCO.2011.38.4099
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.
Maura L. Gillison (2012)



This paper is referenced by
10.1002/hed.24974
Validation of the eighth edition American Joint Committee on Cancer staging system for human papillomavirus‐associated oropharyngeal cancer
John D Cramer (2018)
10.1002/cncr.32501
Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
Emi J. Yoshida (2019)
10.1200/JCO.2016.66.6081
Human Papillomavirus and Oropharyngeal Cancer Stage.
Maura L. Gillison (2016)
10.1002/lary.26965
A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.
Richard Blake Ross (2018)
10.1093/annonc/mdx304
Human papillomavirus-related oropharyngeal cancer
Miren Taberna (2017)
Examining the psychosocial impact of human papillomavirus oropharyngeal cancer
Rachael H Dodd (2016)
10.1634/theoncologist.2017-0116
Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.
Mariana Chávez-MacGregor (2017)
10.1002/hed.25810
Projected oropharyngeal carcinoma incidence among middle-aged US men.
Li Xu (2019)
10.1007/978-3-030-04702-3_4
Human Papillomavirus-Related Head and Neck Cancer
Julie A. Theurer (2019)
10.1016/j.oraloncology.2018.09.018
Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis.
Parul Khare Sinha (2018)
10.1002/mc.22760
Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx
Zhongming Lu (2018)
10.1002/hed.25574
Comparison of contemporary staging systems for oropharynx cancer in a surgically treated multi‐institutional cohort
Olgun Eliçin (2019)
10.1016/j.oraloncology.2017.08.020
Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base.
Kevin Y Zhan (2017)
UvA-DARE ( Digital Academic Repository ) Quality indicators in head and neck oncology
De Ridder (2017)
10.1016/j.oraloncology.2017.08.014
Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer.
Karen S. Anderson (2017)
10.1016/j.otorri.2019.08.002
Valoración de la capacidad pronóstica de la afectación ganglionar de los pacientes con carcinoma de orofaringe en función del estatus HPV
J. Nicolau Costa (2020)
10.3233/CBM-160071
Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.
Glenn J. Hanna (2017)
10.1016/j.oraloncology.2017.07.016
Evaluation of the Xpert® HPV assay in the detection of Human Papillomavirus in formalin-fixed paraffin-embedded oropharyngeal carcinomas.
Maria Gabriella Dona' (2017)
10.1002/cncr.30021
Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Zachary D. Horne (2016)
Oropharyngeal Squamous Cell Carcinoma: Friend Or Foe?
Aijaz Ahmed Khan (2018)
10.1002/hed.26025
A critical appraisal of the clinical applicability and risk of bias of the predictive models for mortality and recurrence in patients with oropharyngeal cancer: Systematic review.
Antonio Palazón-Bru (2019)
10.1016/j.anl.2017.07.010
The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Daisuke Sano (2018)
10.1177/0194599818766035
Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer
Stacey M. Davidson (2018)
10.1177/0194599818815065
Elderly Patients with Advanced Head and Neck Carcinoma: Does Aggressive Treatment Result in Better Outcomes?
I. J. Jang (2019)
10.1007/s00428-016-2015-9
A critical evaluation of lymph node ratio in head and neck cancer
Mark De Ridder (2016)
10.1016/S1470-2045(17)30246-2
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
Allen M Chen (2017)
10.1007/s00405-017-4833-z
Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status
Christian Jacobi (2017)
10.1002/lary.26566
Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States.
Matthew H. Stenmark (2017)
10.1002/cncr.31104
Treatment deintensification in human papillomavirus‐positive oropharynx cancer: Outcomes from the National Cancer Data Base
Shayan Cheraghlou (2018)
10.1007/s00405-018-4954-z
Highlights from the Second International Symposium on HPV infection in head and neck cancer
Susanne Wiegand (2018)
10.1007/978-3-319-78762-6_21
Treatment Paradigms in HPV-Associated SCCHN
Christien A. Kluwe (2018)
10.1001/jamaoncol.2016.3510
Human Papillomavirus-Associated Oropharyngeal Cancer: Not Just White Men Anymore.
Kristina R Dahlstrom (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar